Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Recent & Breaking News (NDAQ:BNTX)

UPCOMING BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 29, 2024

BNTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Newsfile February 28, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BNTX

Accesswire February 28, 2024

BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit

PR Newswire February 28, 2024

Levi & Korsinsky Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline - BNTX

Accesswire February 28, 2024

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 28, 2024

Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE (BNTX) Investors of March 12, 2024 Lead Plaintiff Deadline and Urges Investors with Substantial Losses to Contact the Firm

Newsfile February 28, 2024

BioNTech SE Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 28, 2024

Levi & Korsinsky Reminds BioNTech Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire February 28, 2024

DEADLINE ALERT: Bernstein Liebhard LLP Reminds BioNTech SE Investors of Upcoming Deadline

Accesswire February 28, 2024

BioNTech SE Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 28, 2024

Levi & Korsinsky Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire February 28, 2024

UPCOMING BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 28, 2024

BioNTech Ongoing Deadline Alert

Newsfile February 27, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) Shareholders

Accesswire February 27, 2024

Lost Money on BioNTech SE (BNTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Accesswire February 27, 2024

BNTX DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Newsfile February 27, 2024

March 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BNTX

Accesswire February 27, 2024

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 27, 2024

Investors in BioNTech SE Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 27, 2024